The reduction in price target by UBS suggests a less optimistic outlook on Clorox's future stock performance, potentially leading to a negative short-term impact on its stock price. The Neutral rating indicates that UBS does not see significant upside or downside from the current price level, but the lowering of the price target could influence market perception negatively.